Palatin Technologies, Inc. (PTN)

12.70 -0.38 (-2.91%) USD  |  NASDAQ  |  Sep 04, 16:00
12.79 +0.09 (+0.71%) After-Hours: 20:00
More

Palatin Technologies SG&A Expense (TTM) : 9.402M for March 31, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PTN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
March 31, 2026 9.402M
December 31, 2025 8.892M
September 30, 2025 7.449M
June 30, 2025 7.809M
March 31, 2025 9.181M
December 31, 2024 9.74M
September 30, 2024 11.09M
June 30, 2024 12.27M
March 31, 2024 13.34M
December 31, 2023 14.84M
September 30, 2023 14.98M
June 30, 2023 15.29M
March 31, 2023 16.57M
December 31, 2022 16.04M
September 30, 2022 16.18M
June 30, 2022 16.51M
March 31, 2022 16.11M
December 31, 2021 17.11M
September 30, 2021 18.84M
June 30, 2021 17.34M
March 31, 2021 14.84M
December 31, 2020 12.91M
September 30, 2020 10.26M
June 30, 2020 9.765M
March 31, 2020 10.06M
Date Value
December 31, 2019 9.806M
September 30, 2019 9.491M
June 30, 2019 9.699M
March 31, 2019 9.009M
December 31, 2018 9.601M
September 30, 2018 9.138M
June 30, 2018 8.642M
March 31, 2018 7.902M
December 31, 2017 10.26M
September 30, 2017 9.945M
June 30, 2017 9.610M
March 31, 2017 9.503M
December 31, 2016 6.139M
September 30, 2016 6.188M
June 30, 2016 6.179M
March 31, 2016 5.972M
December 31, 2015 5.696M
September 30, 2015 5.763M
June 30, 2015 5.678M
March 31, 2015 5.396M
December 31, 2014 5.475M
September 30, 2014 5.032M
June 30, 2014 4.961M
March 31, 2014 5.161M
December 31, 2013 5.028M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Decoy Therapeutics, Inc. 4.096M
ACADIA Pharmaceuticals, Inc. 620.29M
Alnylam Pharmaceuticals, Inc. 1.318B
Anika Therapeutics, Inc. 52.67M
Savara, Inc. 56.71M